Close Menu

The Wall Street Journal says to expect "an uptick in acquisitions of small and midsize drug companies" but that large pharma companies are "not going on reckless shopping sprees." Bristol-Myers' Karen LaRochelle said that many in Big Pharma do have a bit of cash "and there's a lot of pressure for us to build our pipelines." Merck's Richard Kender adds that, due to the current market, deals that in the past may have been deemed "marginal" are now more likely.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.